Lv1
40 积分 2025-09-15 加入
Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: Evidence for reduced treatment durability across neurologic and aesthetic indications
11小时前
已完结
Efficacy and Safety of a New Botulinum Toxin (HU-014) Versus Existing Onabotulinumtoxin A in Subjects With Moderate to Severe Glabellar Lines
14小时前
已完结
Botulinum Toxin Type A Immunogenicity across Multiple Indications: An Overview Systematic Review
3天前
已完结
Diffusion dimensionality modeling of subcutaneous/intramuscular absorption of antibodies and long-acting injectables
5天前
已完结
Iatrogenic botulism following botulinum toxin injection: a scoping review of clinical characteristics, risk factors, and dermal considerations
21天前
已完结
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment
1个月前
已完结
Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines
1个月前
已关闭
Micro injection of botulinum and its effects on the skin
1个月前
已完结
DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China
1个月前
已完结
Immunogenicity risk mitigation of therapeutic proteins with translational immunogenicity, analytical characterization, and regulatory insight
2个月前
已关闭
皖公网安备34019202002308
